BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31843845)

  • 1. Study protocol for the Melbourne Infant Study: BCG for Allergy and Infection Reduction (MIS BAIR), a randomised controlled trial to determine the non-specific effects of neonatal BCG vaccination in a low-mortality setting.
    Messina NL; Gardiner K; Donath S; Flanagan K; Ponsonby AL; Shann F; Robins-Browne R; Freyne B; Abruzzo V; Morison C; Cox L; Germano S; Zufferey C; Zimmermann P; Allen KJ; Vuillermin P; South M; Casalaz D; Curtis N
    BMJ Open; 2019 Dec; 9(12):e032844. PubMed ID: 31843845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEBBLES study protocol: a randomised controlled trial to prevent atopic dermatitis, food allergy and sensitisation in infants with a family history of allergic disease using a skin barrier improvement strategy.
    Lowe A; Su J; Tang M; Lodge CJ; Matheson M; Allen KJ; Varigos G; Sasi A; Cranswick N; Hamilton S; Robertson CF; Hui J; Abramson M; O'Brien S; Dharmage S
    BMJ Open; 2019 Mar; 9(3):e024594. PubMed ID: 30867201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal Bacille Calmette-Guérin Vaccination and Infections in the First Year of Life: The MIS BAIR Randomized Controlled Trial.
    Messina NL; Pittet LF; Gardiner K; Freyne B; Francis KL; Zufferey C; Abruzzo V; Morrison C; Allen KJ; Flanagan KL; Ponsonby AL; Robins-Browne R; Shann F; South M; Vuillermin P; Donath S; Casalaz D; Curtis N
    J Infect Dis; 2021 Oct; 224(7):1115-1127. PubMed ID: 34146093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCG vaccination to reduce the impact of COVID-19 in healthcare workers: Protocol for a randomised controlled trial (BRACE trial).
    Pittet LF; Messina NL; Gardiner K; Orsini F; Abruzzo V; Bannister S; Bonten M; Campbell JL; Croda J; Dalcolmo M; Elia S; Germano S; Goodall C; Gwee A; Jamieson T; Jardim B; Kollmann TR; Guimarães Lacerda MV; Lee KJ; Legge D; Lucas M; Lynn DJ; McDonald E; Manning L; Munns CF; Perrett KP; Prat Aymerich C; Richmond P; Shann F; Sudbury E; Villanueva P; Wood NJ; Lieschke K; Subbarao K; Davidson A; Curtis N;
    BMJ Open; 2021 Oct; 11(10):e052101. PubMed ID: 34711598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of infant eczema by neonatal Bacillus Calmette-Guérin vaccination: The MIS BAIR randomized controlled trial.
    Pittet LF; Messina NL; Gardiner K; Freyne B; Abruzzo V; Francis KL; Morrison C; Zufferey C; Vuillermin P; Allen KJ; Ponsonby AL; Robins-Browne R; Shann F; Flanagan KL; Phillips R; Donath S; Casalaz D; Curtis N
    Allergy; 2022 Mar; 77(3):956-965. PubMed ID: 34309859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of neonatal BCG vaccination on in vitro cytokine responses to Plasmodium falciparum.
    Messina NL; Wang M; Forbes EK; Freyne B; Hasang WP; Germano S; Bonnici R; Summons F; Gardiner K; Donath S; Gordon R; Rogerson SJ; Curtis N
    BMC Immunol; 2024 Apr; 25(1):24. PubMed ID: 38689233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can earlier BCG vaccination reduce early infant mortality? Study protocol for a cluster randomised trial in Guinea-Bissau.
    Thysen SM; Jensen AKG; Rodrigues A; Borges IDS; Aaby P; Benn C; Fisker A
    BMJ Open; 2019 Sep; 9(9):e025724. PubMed ID: 31551370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCG-induced non-specific effects on heterologous infectious disease in Ugandan neonates: an investigator-blind randomised controlled trial.
    Prentice S; Nassanga B; Webb EL; Akello F; Kiwudhu F; Akurut H; Elliott AM; Arts RJW; Netea MG; Dockrell HM; Cose S;
    Lancet Infect Dis; 2021 Jul; 21(7):993-1003. PubMed ID: 33609457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PrEggNut Study: protocol for a randomised controlled trial investigating the effect of a maternal diet rich in eggs and peanuts from <23 weeks' gestation during pregnancy to 4 months' lactation on infant IgE-mediated egg and peanut allergy outcomes.
    Palmer DJ; Sullivan TR; Campbell DE; Nanan R; Gold MS; Hsu PS; Netting MJ; McWilliam V; Koplin JJ; Perrett KP; Quinn P; O'Sullivan M; Prescott SL; Grivell R; Makrides M
    BMJ Open; 2022 Jun; 12(6):e056925. PubMed ID: 35697444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of neonatal BCG vaccination on atopy and asthma at age 7 to 14 years: an historical cohort study in a community with a very low prevalence of tuberculosis infection and a high prevalence of atopic disease.
    Marks GB; Ng K; Zhou J; Toelle BG; Xuan W; Belousova EG; Britton WJ
    J Allergy Clin Immunol; 2003 Mar; 111(3):541-9. PubMed ID: 12642835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised controlled trial of paracetamol or ibuprofen, as required for fever and pain in the first year of life, for prevention of asthma at age 6 years: paracetamol or ibuprofen in the primary prevention of asthma in Tamariki (PIPPA Tamariki) protocol.
    Tan E; Braithwaite I; McKinlay C; Riley J; Hoare K; Okesene-Gafa K; Semprini A; Sheridan N; Grant C; Johnson D; Weatherall M; Asher I; Beasley R; Dalziel SR
    BMJ Open; 2020 Dec; 10(12):e038296. PubMed ID: 33303437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does BCG vaccination protect against childhood asthma? Final results from the Manchester Community Asthma Study retrospective cohort study and updated systematic review and meta-analysis.
    Linehan MF; Nurmatov U; Frank TL; Niven RM; Baxter DN; Sheikh A
    J Allergy Clin Immunol; 2014 Mar; 133(3):688-95.e14. PubMed ID: 24084077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age at bacille Calmette-Guérin vaccination and risk of allergy and asthma.
    Bager P; Rostgaard K; Nielsen NM; Melbye M; Westergaard T
    Clin Exp Allergy; 2003 Nov; 33(11):1512-7. PubMed ID: 14616862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can BCG vaccination at first health-facility contact reduce early infant mortality? Study protocol for a cluster-randomised trial (CS-BCG).
    Thysen SM; Møller Jensen A; Vedel JO; da Silva Borges I; Aaby P; Jensen AKG; Benn CS; Fisker AB
    BMJ Open; 2022 Nov; 12(11):e063872. PubMed ID: 36410811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower prevalence of reported asthma in adolescents with symptoms of rhinitis that received neonatal BCG.
    da Cunha SS; Cruz AA; Dourado I; Barreto ML; Ferreira LD; Rodrigues LC
    Allergy; 2004 Aug; 59(8):857-62. PubMed ID: 15230819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol for an outcome assessor-blinded pilot randomised controlled trial of an ion-exchange water softener for the prevention of atopic eczema in neonates, with an embedded mechanistic study: the Softened Water for Eczema Prevention (SOFTER) trial.
    Jabbar-Lopez ZK; Gurung N; Greenblatt D; Briley A; Chalmers JR; Thomas KS; Frost T; Kezic S; Common JEA; Kong HH; Segre JA; Danby S; Cork MJ; Peacock JL; Flohr C
    BMJ Open; 2019 Aug; 9(8):e027168. PubMed ID: 31434765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the non-specific effects of BCG vaccination on the innate immune system in Ugandan neonates: study protocol for a randomised controlled trial.
    Prentice S; Webb EL; Dockrell HM; Kaleebu P; Elliott AM; Cose S
    Trials; 2015 Apr; 16():149. PubMed ID: 25872925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive Antenatal Educational Program on Allergic Diseases (PAEPAD) versus standard antenatal care for prevention of atopic dermatitis: study protocol for a single-centre, investigator-blinded randomised controlled trial.
    Zhao M; Liang Y; Song F; Ma L; Wang Y; Gao W; Tian J; Ying X; Shen C; Wang S; Jiao L; Wang Y; Sun X; Ma L; Ma X
    BMJ Open; 2022 Jan; 12(1):e048083. PubMed ID: 35078832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood vaccination and allergy: A systematic review and meta-analysis.
    Navaratna S; Estcourt MJ; Burgess J; Waidyatillake N; Enoh E; Lowe AJ; Peters R; Koplin J; Dhamage SC; Lodge CJ
    Allergy; 2021 Jul; 76(7):2135-2152. PubMed ID: 33569761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentre, randomised trial to investigate early nasal high-flow therapy in paediatric acute hypoxaemic respiratory failure: a protocol for a randomised controlled trial-a Paediatric Acute respiratory Intervention Study (PARIS 2).
    Franklin D; Shellshear D; Babl FE; Schlapbach LJ; Oakley E; Borland ML; Hoeppner T; George S; Craig S; Neutze J; Williams A; Acworth J; McCay H; Wallace A; Mattes J; Gangathimn V; Wildman M; Fraser JF; Moloney S; Gavranich J; Waugh J; Hobbins S; Fahy R; Grew S; Gannon B; Gibbons K; Dalziel S; Schibler A;
    BMJ Open; 2019 Dec; 9(12):e030516. PubMed ID: 31857300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.